Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
MS Center at Evergreen
mi
from
Kirkland, WA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
MS Center at Evergreen
mi
from
Kirkland, WA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
CAMC Health Education and Research Institute
mi
from
Charleston, WV
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
CAMC Health Education and Research Institute
mi
from
Charleston, WV
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Center for Neurological Disorders of Aurora, St. Luke's Medical Center
mi
from
Milwaukee, WI
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Center for Neurological Disorders of Aurora, St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Foothills Medical Center
mi
from
Calgary,
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Foothills Medical Center
mi
from
Calgary,
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Barrow Tuberous Sclerosis Center
mi
from
Phoenix, AZ
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Barrow Tuberous Sclerosis Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
University of California at Los Angeles
mi
from
Los Angeles, CA
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Children's Hospital Oakland Hematology/Oncology Dept
mi
from
Oakland, CA
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Children's Hospital Oakland Hematology/Oncology Dept
mi
from
Oakland, CA
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
University of Chicago Comer Children's Hospital
mi
from
Chicago, IL
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
University of Chicago Comer Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Massachusetts General Hospital Mass General
mi
from
Boston, MA
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Massachusetts General Hospital Mass General
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Children's Hospital Boston SC-1
mi
from
Boston, MA
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Children's Hospital Boston SC-1
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Minnesota Epilepsy Group, P.A.
mi
from
St. Paul, MN
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Minnesota Epilepsy Group, P.A.
mi
from
St. Paul, MN
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp
mi
from
Cincinnati, OH
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Texas Scottish Rite Hospital for Children
mi
from
Dallas, TX
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Texas Scottish Rite Hospital for Children
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Children's Regional Outpatients Center SC
mi
from
Fairfax, VA
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Children's Regional Outpatients Center SC
mi
from
Fairfax, VA
Click here to add this to my saved trials
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated:  1/4/2016
Novartis Investigative Site
mi
from
Randwick,
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)
Status: Enrolling
Updated: 1/4/2016
Novartis Investigative Site
mi
from
Randwick,
Click here to add this to my saved trials
Atomoxetine, Placebo and Parent Management Training in Autism
Atomoxetine, Placebo and Parent Management Training in Autism
Status: Enrolling
Updated:  1/5/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Atomoxetine, Placebo and Parent Management Training in Autism
Atomoxetine, Placebo and Parent Management Training in Autism
Status: Enrolling
Updated: 1/5/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Atomoxetine, Placebo and Parent Management Training in Autism
Atomoxetine, Placebo and Parent Management Training in Autism
Status: Enrolling
Updated:  1/5/2016
Ohio State University
mi
from
Columbus, OH
Atomoxetine, Placebo and Parent Management Training in Autism
Atomoxetine, Placebo and Parent Management Training in Autism
Status: Enrolling
Updated: 1/5/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Atomoxetine, Placebo and Parent Management Training in Autism
Atomoxetine, Placebo and Parent Management Training in Autism
Status: Enrolling
Updated:  1/5/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Atomoxetine, Placebo and Parent Management Training in Autism
Atomoxetine, Placebo and Parent Management Training in Autism
Status: Enrolling
Updated: 1/5/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Optimizing NIPPV Use for Patients With ALS
Effectiveness Trial of Detailed NIPPV Feedback to Patients
Status: Enrolling
Updated:  1/5/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Optimizing NIPPV Use for Patients With ALS
Effectiveness Trial of Detailed NIPPV Feedback to Patients
Status: Enrolling
Updated: 1/5/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study
Lithium Augmentation for Hyperarousal Symptoms of Traumatic Stress Disorder: Pilot Study
Status: Enrolling
Updated:  1/5/2016
Denver Veterans Hospital
mi
from
Denver, CO
Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study
Lithium Augmentation for Hyperarousal Symptoms of Traumatic Stress Disorder: Pilot Study
Status: Enrolling
Updated: 1/5/2016
Denver Veterans Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
San Diego, CA
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Kissimmee, FL
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
St. Petersburg, FL
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Naperville, IL
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Naperville, IL
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
St. Louis, MO
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Lincoln, NE
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
New York, NY
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Rochester, NY
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Petersburg, VA
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Petersburg, VA
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Kirkland, WA
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of South Alabama
mi
from
Mobile, AL
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of South Alabama
mi
from
Mobile, AL
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Arizona
mi
from
Tucson, AZ
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Shanti Clinical Trials (NINDS-CRC site)
mi
from
Colton, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Shanti Clinical Trials (NINDS-CRC site)
mi
from
Colton, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
UCSF-Fresno
mi
from
Fresno, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
UCSF-Fresno
mi
from
Fresno, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Scripps Clinic
mi
from
La Jolla, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of California
mi
from
Los Angeles, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Southern California
mi
from
Los Angeles, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of California-Davis
mi
from
Sacramento, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of California
mi
from
San Diego, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of California
mi
from
San Diego, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of California
mi
from
San Francisco, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of California
mi
from
San Francisco, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Denver Health and Hospital Authority
mi
from
Denver, CO
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Denver Health and Hospital Authority
mi
from
Denver, CO
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Hartford
mi
from
Hartford, CT
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Hartford
mi
from
Hartford, CT
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Yale University
mi
from
New Haven, CT
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
National Rehabilitation Hospital
mi
from
Washington,
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
National Rehabilitation Hospital
mi
from
Washington,
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Florida
mi
from
Gainesville, FL
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Florida
mi
from
Jacksonville, FL
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
MIMA Century Research Associates
mi
from
Melbourne, FL
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
MIMA Century Research Associates
mi
from
Melbourne, FL
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Pines Neurological Associates (NINDS-CRC site)
mi
from
Pembroke Pines, FL
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Pines Neurological Associates (NINDS-CRC site)
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials